Evidence map›Paper›PMID 42177359›Full record

ArticleCommunications biology2026

Reconstitution of protein arginylation pathways in bacteria for robust identification and quantification.

Xin Lan, Richard M Searfoss, Daniel Lee, Sahil Bhaskaran, Thilini Abeywansha, Benjamin A Garcia, Zongtao Lin, Yi Zhang

Abstract read
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xin Lan *Department of Biochemistry, Case Western Reserve University, Cleveland, OH, USA.
Richard M Searfoss *Department of Biochemistry and Molecular Biophysics, Washington University in St. Louis, St. Louis, MO, USA.ORCID 0000-0001-6235-2595
Daniel LeeDepartment of Biochemistry, Case Western Reserve University, Cleveland, OH, USA.
Sahil BhaskaranDepartment of Biochemistry, Case Western Reserve University, Cleveland, OH, USA.ORCID 0009-0003-1197-1945
Thilini AbeywanshaDepartment of Biochemistry, Case Western Reserve University, Cleveland, OH, USA.ORCID 0000-0002-2831-9852
Benjamin A GarciaDepartment of Biochemistry and Molecular Biophysics, Washington University in St. Louis, St. Louis, MO, USA.ORCID 0000-0003-3596-4750
Zongtao LinDepartment of Medicinal Chemistry, Rutgers University, Piscataway, NJ, USA. tom.z.lin@rutgers.edu.ORCID 0000-0002-6017-338X
Yi ZhangDepartment of Biochemistry, Case Western Reserve University, Cleveland, OH, USA. yi.zhang26@case.edu.ORCID 0000-0001-8170-9983

Funding

TUMOR METABOLISM PROGRAMP30CA043703 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI Amar Desai · 1987 to 2026
$142.3M
Research Education ComponentP30AG066444 · NIA · WASHINGTON UNIVERSITY · PI Susan Lynn Stark · 2020 to 2026
$28.7M
RESEARCH ONCOLOGY TRAINING GRANTT32CA059366 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI JACKSON, MARK W. · 1993 to 2025
$5.5M
Arginyl-tRNA beyond translation: mechanism and regulation of protein arginylationR35GM150678 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI Yi Zhang · 2023 to 2026
$1.9M
Development and Application of Chemical Biology Approaches for Understanding Protein ArginylationR01HL177113 · NHLBI · WASHINGTON UNIVERSITY · PI Benjamin A Garcia, Zongtao Lin · 2025 to 2026
$1.2M
Hijacking Post-translational Arginylation for Targeted Protein DegradationR21CA292191 · NCI · WASHINGTON UNIVERSITY · PI LIN, ZONGTAO, LYU, DONGWEN · 2024 to 2024
$426k
NCI NIH HHS P30 CA043703NCI NIH HHS R21 CA292191NCI NIH HHS T32 CA059366NHLBI NIH HHS R01 HL177113NIA NIH HHS P30 AG066444NIGMS NIH HHS R35 GM150678U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) P30CA043703U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R21CA292191U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) T32CA059366U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL177113U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM150678U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) P30AG066444
6 · The paper itself

Abstract

ATE1 is a conserved enzyme that catalyzes the covalent addition of arginine to proteins bearing N-terminal or mid-chain Asp and Glu residues. N-terminal (Nt) arginylation can also occur on Cys, Asn, and Gln following enzymatic conversion, often marking proteins for degradation. Essential for development, this pathway contributes to protein quality control and stress responses. Despite growing insight into ATE1 structure and function, the mechanisms governing its substrate selectivity and coordination with upstream oxygenase and deamidase remain poorly defined. Here, we reconstitute the human processing cascades that generate Nt-arginylated proteins in E. coli, enabling step-resolved analysis of arginylation outcomes in a cellular context. By co-expressing human ADO, NTAN1, or NTAQ1 with ATE1 in a modular system, we achieved efficient conversion of Nt-Cys, Asn, and Gln into arginylation-permissive forms, recapitulating key features of upstream processing. Using this platform, we demonstrated that N-terminal processing is efficient and that ATE1 preferentially modifies protein N-termini over internal acidic residues. Mid-chain arginylation of α-synuclein was detectable but occurred at low frequency, with no major differences in site selectivity observed across the ATE1 isoforms tested. Together, this bacterial reconstitution system provides a scalable experimental platform for quantitative, protein-level analysis of ATE1 substrate specificity under defined conditions.

Indexed as

AminoacyltransferasesArginineEscherichia coliProtein Processing, Post-Translationalalpha-SynucleinAmidohydrolasesDegronsHumansSubstrate Specificityalpha-SynucleinAmidohydrolasesAminoacyltransferasesArginine

Identifiers

PMID42177359
PMCPMC13478464

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.